Evidence-based recommendations or "Show me the patients selected and I will tell you the results"

Respiratory Medicine

Volumn 100, Issue SUPPL. 1, 2006, Pages

  Bjermer, Leif ^a  

^a Department of Respiratory Medicine and Allergology ^*  (Sweden)

Author keywords

Asthma; Clinical trial; Eligibility; Evidence based medicine; Feasibility

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; LONG ACTING DRUG; MONTELUKAST; PLACEBO; SALMETEROL; TRIAMCINOLONE;

ARTICLE; ASTHMA; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE EXACERBATION; DOSE CALCULATION; DRUG MEGADOSE; DRUG RESPONSE; DRUG TREATMENT FAILURE; EVIDENCE BASED MEDICINE; FORCED EXPIRATORY VOLUME; HUMAN; MEDICAL DECISION MAKING; MONOTHERAPY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 33750509210     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.03.023     Document Type: Article

References (15)

1. Recommendations for grading of evidence. Oxford Centre for Evidence Based Medicine. http://www.cebm.net/levels_of_evidence.asp#levels
2. Bisgaard H., and Szefler S. Long-acting β2 agonists and paediatric asthma. Lancet 367 9507 (2006) 286-288
3. Bateman E.D., Boushey H.A., Bousquet J., Busse W.W., Clark T.J., Pauwels R.A., et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med 170 8 (2004) 836-844
4. Nelson H.S., Busse W.W., Kerwin E., Church N., Emmett A., Rickard K., et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol 106 6 (2000) 1088-1095
5. O'Byrne P.M., Barnes P.J., Rodriguez-Roisin R., Runnerstrom E., Sandstrom T., Svensson K., et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 164 8, Part 1 (2001) 1392-1397
6. Lazarus S.C., Boushey H.A., Fahy J.V., Chinchilli V.M., Lemanske R.F., Sorkness C.A., et al. Long-acting beta2-agonist monotherapy vs. continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 285 20 (2001) 2583-2593
7. Storms W., Chervinsky P., Ghannam A.F., Bird S., Hustad C.M., and Edelman J.M. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge. Respir Med 98 11 (2004) 1051-1062
8. Pauwels R.A., Löfdahl C.G., Postma D.S., Tattersfield A.E., O'Byrne P., Barnes P.J., et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 337 20 (1997) 1405-1411
9. Bjermer L., Bisgaard H., Bousquet J., Fabbri L.M., Greening A.P., Haahtela T., et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 327 (2003) 1-6
10. Juniper E.F., Svensson K., O'Byrne P.M., Barnes P.J., Bauer C.A., Löfdahl C.G., et al. Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J 14 5 (1999) 1038-1043
11. Sont J.K., Willems L.N., Bel E.H., van Krieken J.H., Vandenbroucke J.P., and Sterk P.J. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159 4, Part 1 (1999) 1043-1051
12. Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 9347 (2002) 1715-1721
13. Smith A.D., Cowan J.O., Brassett K.P., Herbison G.P., and Taylor D.R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352 21 (2005) 2163-2173
14. Currie G.P., Bates C.E., Lee D.K., Jackson C.M., and Lipworth B.J. Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients. Eur J Clin Pharmacol 59 1 (2003) 11-15
15. Herland K., Akselsen J.P., Skjonsberg O.H., and Bjermer L. How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?. Respir Med 99 1 (2005) 11-19